ID: ALA4798145

Max Phase: Preclinical

Molecular Formula: C13H25NO2

Molecular Weight: 227.35

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCN1CCC[C@H]1C(=O)O

Standard InChI:  InChI=1S/C13H25NO2/c1-2-3-4-5-6-7-10-14-11-8-9-12(14)13(15)16/h12H,2-11H2,1H3,(H,15,16)/t12-/m0/s1

Standard InChI Key:  QUPLKBXQAFTIRK-LBPRGKRZSA-N

Associated Targets(Human)

Epoxide hydrolase 1 644 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 227.35Molecular Weight (Monoisotopic): 227.1885AlogP: 2.90#Rotatable Bonds: 8
Polar Surface Area: 40.54Molecular Species: ZWITTERIONHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.92CX Basic pKa: 10.66CX LogP: 0.66CX LogD: 0.66
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.65Np Likeness Score: -0.25

References

1. Barnych B,Singh N,Negrel S,Zhang Y,Magis D,Roux C,Hua X,Ding Z,Morisseau C,Tantillo DJ,Siegel JB,Hammock BD.  (2020)  Development of potent inhibitors of the human microsomal epoxide hydrolase.,  193  [PMID:32203787] [10.1016/j.ejmech.2020.112206]

Source